Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities.

Source:http://linkedlifedata.com/resource/pubmed/id/15382054

Int. J. Cancer 2004 Nov 20 112 4 701-6

Download in:

View as

General Info

PMID
15382054